Lotus Pharmaceutical Co., Ltd. (TPE: 1795)
Taiwan
· Delayed Price · Currency is TWD
269.50
-1.50 (-0.55%)
Dec 31, 2024, 1:30 PM CST
Lotus Pharmaceutical Revenue
Lotus Pharmaceutical had revenue of 5.23B TWD in the quarter ending September 30, 2024, with 14.45% growth. This brings the company's revenue in the last twelve months to 17.59B, up 5.29% year-over-year. In the year 2023, Lotus Pharmaceutical had annual revenue of 16.96B with 15.89% growth.
Revenue (ttm)
17.59B
Revenue Growth
+5.29%
P/S Ratio
3.93
Revenue / Employee
16.01M
Employees
1,099
Market Cap
70.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.96B | 2.33B | 15.89% |
Dec 31, 2022 | 14.63B | 1.98B | 15.68% |
Dec 31, 2021 | 12.65B | 1.92B | 17.90% |
Dec 31, 2020 | 10.73B | 1.12B | 11.63% |
Dec 31, 2019 | 9.61B | 3.18B | 49.50% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 49.98M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Oneness Biotech | 112.20M |
Lumosa Therapeutics | 37.82M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |
Pegavision | 7.06B |